Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 3 | Unknown | PO / MO |
The patient did not refrigerate Vivotif for the entire time and took three doses; The patient did not refrigerate Vivotif for the entire time and took three doses; The patient did not refrigerate Vivotif for the entire time and took three doses; Case reference number US-BN-2025-000212 is a spontaneous case initially received from a pharmacist via Communication (reference number: USBAV25-0314) on 11-Feb-2025 and concerns a patient of unspecified age and gender. The patient's medical history and concomitant medication details were not provided. On unspecified date, the patient took the first, second and third dose of Vivotif (batch number: unknown), orally, for typhoid immunization. The patient did not refrigerate Vivotif for the entire time and took three doses (explicitly coded as 'Product storage error', 'Product temperature excursion issue' and 'Product administration error'). At the time of the initial report, it was unknown if the patient experienced any of adverse events due Vivotif. No further information was provided.; Reporter's Comments: A patient of unspecified age and gender took the first, second and third dose of Vivotif for typhoid immunization. The patient did not refrigerate Vivotif for the entire time and took three doses, which is considered as product storage error, product temperature excursion issue and product administration error. It was unknown if the patient experienced any of adverse events due Vivotif. Product storage error, product temperature excursion issue and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product storage error, product temperature excursion issue and product administration error are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unspecified age and gender took the first, second and third dose of Vivotif for typhoid immunization. The patient did not refrigerate Vivotif for the entire time and took three doses, which is considered as product storage error, product temperature excursion issue and product administration error. It was unknown if the patient experienced any of adverse events due Vivotif. Product storage error, product temperature excursion issue and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product storage error, product temperature excursion issue and product administration error are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE